Skip to content

Family-based and Adolescent Residential Drug Treatment

Family-Based Versus Adolescent Residential Drug Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01737632
Acronym
ART
Enrollment
113
Registered
2012-11-29
Start date
2000-08-31
Completion date
2010-06-30
Last updated
2012-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delinquency, Substance Use

Keywords

Adolescents, Residential Treatment, Outpatient Treatment, Substance Abuse, Delinquency, Family Therapy, Multidimensional Family therapy

Brief summary

The fundamental objective of this study is to compare the effectiveness of an intensive in-home family-based treatment, Multidimensional Family Therapy, with a multifaceted residential treatment, Adolescent Residential Treatment, over 4 years post-intake and to delineate the mechanisms of change for each treatment. The study targets dually- diagnosed adolescent drug abusers recommended for residential treatment.

Detailed description

Aim 1: To compare the effectiveness of residential treatment with outpatient, family-based treatment multiple outcomes including substance use, mental health, school functioning, family function and delinquency among dually diagnosed adolescents. Hypothesis 1. From intake to 2 months, residential treatment will show better outcomes than the family based treatment. Between 2 months and 18 months, family based treatment will show better outcomes than residential. Between 18 months and four years post intake, outpatient family based treatment will maintain its treatment gains, while the residential treatment condition will show an increase in these same symptoms and behaviors. Aim 2: To examine the relationship between predictors (family, peer, educational/vocational functioning and involvement in post-treatment services), and outcomes (drug use, co-morbid symptoms, and criminal behavior) during the four-year post intake period. Hypothesis 2a. Family functioning, educational/vocational functioning, and peer relationships measured at discharge will predict drug use, co-morbid symptoms, and criminal behaviors though the four year longer term follow up period. Hypothesis 2b. Family functioning, educational/vocational functioning, peer relationships, and involvement in post-treatment services during the post treatment period will predict drug use, co-morbid symptoms, and criminal behavior through the longer term follow up period. Research Question 1. Is the rate of change in family functioning, educational/vocational functioning, peer relationships, and involvement in post-treatment services related to the rate of change in drug use, co-morbid symptoms, and criminal behavior?

Interventions

BEHAVIORALMultidimensional Family Therapy (MDFT)

MDFT assesses and intervenes in five domains: 1) Interventions with the adolescent, 2) interventions with the parent, 3) interventions to improve the parent-adolescent relationship, 4) interventions with other family members, and 5) interventions with external systems.

BEHAVIORALAdolescent Residential Treatment

The Adolescent Treatment Program targets the adolescent's abuse or dependency on chemicals while simultaneously treating the comorbid symptomatology found in dual diagnosed patients. These goals are accomplished by using four primary forms of intervention: (1) Chemical Education; (2) Group, Individual and Family Counseling; (3) Twelve Step Work; and 4) Psychotropic Medication for Clinical Symptomatology Comorbid with Substance Abuse.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
13 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Youth between the ages of 13 and 17 * Referred to ATP for residential substance abuse treatment in youth dual diagnosis program * Dually diagnosed for substance abuse or dependence and at least one of the following co-morbid conditions: major depressive disorder, bipolar disorder, I conduct disorder, oppositional defiant disorder, * At least one parent or parent-figure can be located at the time of referral. * Obtain informed consent from a parent or formal guardian and assent from youth to participate in the study.

Exclusion criteria

* Have any of the following disorders: Mental Retardation, Eating Disorders, Schizophrenia, or Pervasive Developmental Disorders. * Current suicidality.

Design outcomes

Primary

MeasureTime frameDescription
Change in internalzing symptomsIntake, 2, 4, 12, 18, 24, 36, 48 months after baselineMeasured by the Youth Self Report (YSR)
Change in substance use consumptionBaseline, 2, 4, 12,18,24,36,48 months after intakeMeasure of substance use consumption as measured by the Timeline Follow-back Method.
Change in externalizing symptomsBaseline, 2, 4, 12, 18, 24, 36 and 48 monthsExternalizing symptoms measured by the Youth Self Report
Change in delinquencyIntake, 2, 4, 12, 18, 24, 35, 48 months after intakeMeasured by youth report on the Self Report Delinquency Scale.
Change in Personal Involvement with ChemicalsBaseline, 2, 4, 12, 18, 24, 36 and 48 months after baselineScale from the Personal Experience Inventory (PEI) developed by Ken Winter.

Secondary

MeasureTime frameDescription
Change in parenting practicesBaseline, 2, 4, 12, 18, 24,36, 48 months after baselineMeasures the extent to which parents monitor, set limits, and provide affection to their teens.
Change in family conflictBaseline, 2, 4, 12, 18, 24, 36, 48 months after baselineParent and youth report on their family conflict as measured by the Family Environment Scale.
Change in family cohesionIntake, 2, 4, 12, 18, 24, 26, 48 months after intakeYouth and parent reports of family closeness measured by the Family Environment Scale (FES)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026